Evidence map›Paper›PMID 40392909›Full record

ArticlePLoS medicine2025

Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America.

Sabine Naudin, Molin Wang, Niki Dimou, Elmira Ebrahimi, Jeanine Genkinger, Hans-Olov Adami, Demetrius Albanes, Ana Babic, Matt Barnett, David Bogumil and 64 more

Abstract read
In one paragraph

Article in PLoS medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Exploring correlations of CA19-9 with serum enzyme ratios: can layered biomarker strategies enhance prognostic accuracy in pancreatic cancer?Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Is Heavy Alcohol Use Associated With Young-Onset Pancreatic Cancer?Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Idiopathic chronic pancreatitis: clinical highlights.Therapeutic advances in gastroenterology · 2026
    Review
  13. Article
  14. CREB Fuels Tumorigenesis in Alcoholic Pancreatitis.Cellular and molecular gastroenterology and hepatology · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

74 authors.

Sabine NaudinInternational Agency for Research on Cancer, World Health Organization, Lyon, France.ORCID https://orcid.org/0000-0003-1049-6225
Molin WangDepartment of Epidemiology, Harvard TH Chan School of Public Health, Boston, Massachusetts, United States of America.
Niki DimouInternational Agency for Research on Cancer, World Health Organization, Lyon, France.
Elmira EbrahimiInternational Agency for Research on Cancer, World Health Organization, Lyon, France.
Jeanine GenkingerDepartment of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York, New York, United States of America.
Hans-Olov AdamiDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0001-9592-5791
Demetrius AlbanesDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.
Ana BabicDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.
Matt BarnettDivision of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
David BogumilDepartment of Population and Public Health Sciences, Keck School of Medicine of USC, Los Angeles, California, United States of America.ORCID https://orcid.org/0000-0002-5001-1088
Hui CaiDivision of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Chu ChenProgram in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
A Heather EliassenDepartment of Epidemiology, Harvard TH Chan School of Public Health, Boston, Massachusetts, United States of America.
Jo L FreudenheimDepartment of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, New York, United States of America.
Gretchen GierachDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.ORCID https://orcid.org/0000-0002-0165-5522
Edward L GiovannucciDepartment of Epidemiology, Harvard TH Chan School of Public Health, Boston, Massachusetts, United States of America.ORCID https://orcid.org/0000-0002-6123-0219
Marc J GunterInternational Agency for Research on Cancer, World Health Organization, Lyon, France.
Niclas HåkanssonDepartment of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0001-7673-5554
Mayo HirabayashiDivision of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Tao HouDepartment of Nutrition, Harvard TH Chan School of Public Health, Boston, Massachusetts, United States of America.ORCID https://orcid.org/0009-0002-9144-8996
Brian Z HuangDepartment of Population and Public Health Sciences, Keck School of Medicine of USC, Los Angeles, California, United States of America.
Wen-Yi HuangDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.
Harindra JayasekaraCancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
Michael E JonesDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.
Verena A KatzkeDivision of Cancer Epidemiology, Nutritional Epidemioloy, German Cancer Research Center, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-6509-6555
Woon-Puay KohHealthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.ORCID https://orcid.org/0000-0002-5674-6341
James V LaceyDepartment of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope, Duarte, California, United States of America.
Ylva Trolle LagerrosDepartment of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0001-6816-7577
Susanna C LarssonDepartment of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Linda M LiaoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.
Kenneth LoDepartment of Food Science and Nutrition, The Hong Kong Polytechnic University, Hong Kong SAR, China.ORCID https://orcid.org/0000-0003-4624-2737
Erikka LoftfieldDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.ORCID https://orcid.org/0000-0002-3573-8748
Robert J MacInnisCancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
Satu MännistöDepartment of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
Marjorie L McCulloughDepartment of Population Science, American Cancer Society, Atlanta, Georgia, United States of America.
Anthony MillerDalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Roger L MilneCancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0001-5764-7268
Steven C MooreDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.ORCID https://orcid.org/0000-0002-8169-1661
Lorelei A MucciDepartment of Epidemiology, Harvard TH Chan School of Public Health, Boston, Massachusetts, United States of America.
Marian L NeuhouserDivision of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Alpa V PatelDepartment of Population Science, American Cancer Society, Atlanta, Georgia, United States of America.
Elizabeth A PlatzDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.ORCID https://orcid.org/0000-0003-3676-8954
Anna PrizmentDepartment of Laboratory Medicine and Pathology, University of Minnesota Medical School, and the University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, United States of America.ORCID https://orcid.org/0000-0001-5924-6871
Kim RobienDepartment of Exercise and Nutrition Sciences, Milken Institute School of Public Health, George Washington University, Washington District of Columbia, United States of America.ORCID https://orcid.org/0000-0002-2120-2280
Thomas E RohanDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, New York, United States of America.
Carlotta SacerdoteUnit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention, Turin, Italy.ORCID https://orcid.org/0000-0002-8008-5096
Sven SandinDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0001-6994-4884
Norie SawadaDivision of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Minouk SchoemakerIQVIA, Global Database Studies, Amsterdam, The Netherlands.
Xiao-Ou ShuDivision of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Rashmi SinhaDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.
Linda SnetselaarUniversity of Iowa, Iowa City, Iowa, United States of America.
Meir J StampferDepartment of Epidemiology, Harvard TH Chan School of Public Health, Boston, Massachusetts, United States of America.
Rachael Stolzenberg-SolomonDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.
Cynthia A ThomsonMel & Enid Zuckerman College of Public Health, University of Arizona Cancer Center, Tucson, Arizona, United States of America.
Anne TjønnelandDanish Cancer Institute, Diet, Cancer and Health, Copenhagen, Denmark.ORCID https://orcid.org/0000-0003-4385-2097
Caroline Y UmDepartment of Population Science, American Cancer Society, Atlanta, Georgia, United States of America.ORCID https://orcid.org/0000-0001-5449-6230
Piet A van den BrandtDepartment of Epidemiology, Maastricht University, Maastricht, The Netherlands.ORCID https://orcid.org/0000-0001-8781-8099
Kala VisvanathanDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Sophia S WangDepartment of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope, Duarte, California, United States of America.
Renwei WangUniversity of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, Pennsylvania, United States of America.
Elisabete WeiderpassInternational Agency for Research on Cancer, World Health Organization, Lyon, France.
Stephanie J WeinsteinDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.ORCID https://orcid.org/0000-0002-3834-1535
Emily WhiteFred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Walter WillettDepartment of Epidemiology, Harvard TH Chan School of Public Health, Boston, Massachusetts, United States of America.ORCID https://orcid.org/0000-0003-1458-7597
Alicja WoslkDepartment of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0001-7387-6845
Brian M WolpinDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.
Shiaw-Shyuan S YaunDepartment of Nutrition, Harvard TH Chan School of Public Health, Boston, Massachusetts, United States of America.
Chen YuanDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America.
Jian-Min YuanUniversity of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, Pennsylvania, United States of America.ORCID https://orcid.org/0000-0002-4620-3108
Wei ZhengDivision of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.ORCID https://orcid.org/0000-0003-1226-070X
Paul BrennanInternational Agency for Research on Cancer, World Health Organization, Lyon, France.
Stephanie A Smith-WarnerDepartment of Epidemiology, Harvard TH Chan School of Public Health, Boston, Massachusetts, United States of America.ORCID https://orcid.org/0000-0003-3462-8608
Pietro FerrariInternational Agency for Research on Cancer, World Health Organization, Lyon, France.ORCID https://orcid.org/0000-0001-9358-7338

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI John Charles Williams · 1985 to 2026
$86.3M
Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, TAMIMI, RULLA M · 2000 to 2019
$77.8M
WOMEN'S HEALTH INITIATIVE - CLINICAL COORDINATING CENTER: TASK AREA B - LONG LIFE STUDY VISIT 2 LIMITED HOME VISIT75N92021D00001 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ANDERSON, GARNET L. · 2021 to 2025
$52.0M
Understanding Population Differences in Cancer: The MEC StudyU01CA164973 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI HAIMAN, CHRISTOPHER ALAN, LE MARCHAND, LOIC · 2015 to 2025
$37.4M
CALIFORNIA TEACHERS STUDYR01CA077398 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERNSTEIN, LESLIE · 1998 to 2014
$29.7M
Life Course Cancer Epidemiology Cohort in WomenU01CA176726 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI ELIASSEN, A. HEATHER, WILLETT, WALTER C. · 2018 to 2025
$22.4M
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3M
Oil and Gas as Drivers of Climate Change and Health: Developing unique resources to investigate multi-level and diverse effects of exposure to oil and gas wellsU01CA199277 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI LACEY, JAMES V, MARTINEZ, MARIA ELENA · 2015 to 2024
$20.7M
Integrating lifecourse approaches, biologic and digital phenotypes in support of heart and lung disease epidemiologic researchU01HL145386 · NHLBI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI CHAVARRO, JORGE EDUARDO, MANSON, JOANN ELISABETH · 2019 to 2025
$17.8M
Cancer Epidemiology Cohort in Male Health ProfessionalsU01CA167552 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Lorelei Mucci, Walter C. Willett · 2017 to 2026
$17.0M
THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)U01CA063673 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GOODMAN, GARY E · 1994 to 2006
$13.0M
NCI NIH HHS P01 CA087969NCI NIH HHS P30 CA023100NCI NIH HHS P30 CA033572NCI NIH HHS R01 CA039742NCI NIH HHS R01 CA043092NCI NIH HHS R01 CA077398NCI NIH HHS R01 CA080205NCI NIH HHS R01 CA144034NCI NIH HHS U01 CA063673NCI NIH HHS U01 CA086308NCI NIH HHS U01 CA164973NCI NIH HHS U01 CA167462NCI NIH HHS U01 CA167552NCI NIH HHS U01 CA176726NCI NIH HHS U01 CA182876NCI NIH HHS U01 CA199277NCI NIH HHS U01 CA210171NCI NIH HHS UM1 CA164917NCI NIH HHS UM1 CA167462NCI NIH HHS UM1 CA173640NCI NIH HHS UM1 CA182876NCI NIH HHS UM1 CA186107NHLBI NIH HHS 75N92021D00001NHLBI NIH HHS 75N92021D00002NHLBI NIH HHS U01 HL145386NIAAA NIH HHS R01 AA024770NIA NIH HHS U01 AG018033WHI NIH HHS 75N92021D00003WHI NIH HHS 75N92021D00004WHI NIH HHS 75N92021D00005World Health Organization 001
6 · The paper itself

Abstract

backgroundAlcohol is a known carcinogen, yet the evidence for an association with pancreatic cancer risk is considered as limited or inconclusive by international expert panels. We examined the association between alcohol intake and pancreatic cancer risk in a large consortium of prospective studies. METHODS AND

findingsPopulation-based individual-level data was pooled from 30 cohorts across four continents, including Asia, Australia, Europe, and North America. A total of 2,494,432 participants without cancer at baseline (62% women, 84% European ancestries, 70% alcohol drinkers [alcohol intake ≥ 0.1 g/day], 47% never smokers) were recruited between 1980 and 2013 at the median age of 57 years and 10,067 incident pancreatic cancer cases were recorded. In age- and sex-stratified Cox proportional hazards models adjusted for smoking history, diabetes status, body mass index, height, education, race and ethnicity, and physical activity, pancreatic cancer hazard ratios (HR) and 95% confidence intervals (CI) were estimated for categories of alcohol intake and in continuous for a 10 g/day increase. Potential heterogeneity by sex, smoking status, geographic regions, and type of alcoholic beverage was investigated. Alcohol intake was positively associated with pancreatic cancer risk, with HR30-to-<60 g/day and HR≥60 g/day equal to 1.12 (95% CI [1.03,1.21]) and 1.32 (95% CI [1.18,1.47]), respectively, compared to intake of 0.1 to <5 g/day. A 10 g/day increment of alcohol intake was associated with a 3% increased pancreatic cancer risk overall (HR: 1.03; 95% CI [1.02,1.04]; pvalue < 0.001) and among never smokers (HR: 1.03; 95% CI [1.01,1.06]; pvalue = 0.006), with no evidence of heterogeneity by sex (pheterogeneity = 0.274) or smoking status (pheterogeneity = 0.624). Associations were consistent in Europe-Australia (HR10 g/day = 1.03, 95% CI [1.00,1.05]; pvalue = 0.042) and North America (HR10 g/day = 1.03, 95% CI [1.02,1.05]; pvalue < 0.001), while no association was observed in cohorts from Asia (HR10 g/day = 1.00, 95% CI [0.96,1.03]; pvalue = 0.800; pheterogeneity = 0.003). Positive associations with pancreatic cancer risk were found for alcohol intake from beer (HR10 g/day = 1.02, 95% CI [1.00,1.04]; pvalue = 0.015) and spirits/liquor (HR10 g/day = 1.04, 95% CI [1.03,1.06]; pvalue < 0.001), but not wine (HR10 g/day = 1.00, 95% CI [0.98,1.03]; pvalue = 0.827). The differential associations across geographic regions and types of alcoholic beverages might reflect differences in drinking habits and deserve more investigations.

conclusionsFindings from this large-scale pooled analysis support a modest positive association between alcohol intake and pancreatic cancer risk, irrespective of sex and smoking status. Associations were particularly evident for baseline alcohol intake of at least 15 g/day in women and 30 g/day in men.

Indexed as

Alcohol DrinkingPancreatic NeoplasmsAdultAgedAsiaAustraliaEuropeFemaleHumansIncidenceMaleMiddle AgedNorth AmericaProportional Hazards ModelsProspective StudiesRisk Factors

Identifiers

PMID40392909
PMCPMC12091891

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.